Nucleophosmin – qPCR for monitoring

Diagnostic Use

Quantitation of nucleophosmin (NPM1) mutation transcripts to monitor measurable residual disease (MRD) in acute myeloid leukaemia (AML) patients who had a NPM1 variant (Type A, B or D) detected at diagnosis. This assay can also be used at diagnosis to determine if there is a NPM1 mutation present - please note that it will only detect NPM1 Type A, B or D variants.

Department

Genetics, Genetics - Molecular Oncology

Delphic Registration Code

MONC

Laboratory Handling

Phlebotomy

3x EDTA (Lavender) dedicated to Genetics

Registration

Send to MONC

Synonyms

NPM1

Turnaround Time

5 days